This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tarnacka, B. Articles by Czlonkowska, A. Search for Related Content PubMed PubMed Citation Articles by Tarnacka, B. Articles by Czlonkowska, A. Pubmed/NCBI databases Medline Plus Health Information Stroke Related Collections Risk Factors Acute Cerebral Infarction Risk Factors for Stroke

(Stroke. 2002;33:936.)
© 2002 American Heart Association, Inc.

Original Contributions

Increased Circulating Immune Complexes in Acute Stroke

The Triggering Role of Chlamydia pneumoniae and Cytomegalovirus

Beata Tarnacka, MD; Gräyna Gromadzka, MS Anna Czonkowska, MD, PhD

From the Second Department of Neurology (B.T., G.G., A.C.), Institute of Psychiatry and Neurology, and Department of Experimental and Clinical Pharmacology (G.G., A.C.), Medical Academy, Warsaw, Poland.

Correspondence to Prof. Anna Czonkowska, Institute of Psychiatry and Neurology, Second Department of Neurology, Sobieskiego 1/9, 02-957 Warsaw, Poland. E-mail czlonkow{at}ipin.edu.pl

Background and Purpose— The mechanisms of immune reaction involved in the pathogenesis and clinical course of acute vascular incidents are still not completely understood. The aim of this study was to examine the presence of immune complexes (IC) in the acute stroke setting and the first month thereafter and to characterize IC by analyzing the contents of chlamydial lipopolysaccharide and anti-cytomegalovirus (CMV) antibodies in IC.

Methods— Serum concentration of IC was investigated in 179 stroke patients, 122 "old" controls and 112 "young" controls, by the precipitation method. The presence of chlamydial lipopolisaccharyde and anti-CMV antibodies was investigated in some IC preparations by the ELISA method after earlier dissociation of IC into components by high pH treatment.

Results— Significantly increased serum IC concentration in stroke patients was noticed. Increased serum IC concentration was revealed as an independent strong stroke risk factor and was connected with significantly worse neurological status and increased 30-day mortality rate. A significantly larger proportion of stroke patients than controls had Chlamydia pneumoniae antigen and anti-CMV antibodies in IC.

Conclusions— This study provides the first evidence of an association between increased serum level of IC and the clinical course of cerebral ischemia and identifies a potentially important association of C pneumoniae and CMV-specific IC with stroke incidence.

Key Words: immune complexes • infection • stroke, ischemic

This article has been cited by other articles:

				J. Parratt, R. Tavendale, J. O'Riordan, D. Parratt, and R. Swingler Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis Multiple Sclerosis, April 1, 2008; 14(3): 292 - 299. [Abstract] [PDF]

				L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Circulation, June 20, 2006; 113(24): e873 - e923. [Abstract] [Full Text] [PDF]

				L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke, June 1, 2006; 37(6): 1583 - 1633. [Abstract] [Full Text] [PDF]

				M. Di Napoli and A. Arakelyan POEMS Syndrome, Fibrinogen, and Ischemic Stroke: A Critical Point of View Arch Neurol, January 1, 2004; 61(1): 155 - 155. [Full Text] [PDF]

				P. J. Lindsberg and A. J. Grau Inflammation and Infections as Risk Factors for Ischemic Stroke Stroke, October 1, 2003; 34(10): 2518 - 2532. [Abstract] [Full Text] [PDF]